Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.

Autor: Maurel M; Epiconcept, Paris, France., Howard J; Epiconcept, Paris, France., Kissling E; Epiconcept, Paris, France., Pozo F; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.; National Centre for Microbiology, National Influenza Reference Laboratory, WHO-National Influenza Centre, Institute of Health Carlos III, Madrid, Spain., Pérez-Gimeno G; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Buda S; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany., Sève N; Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France., McKenna A; HSE Health Protection Surveillance Centre, Dublin, Ireland., Meijer A; National Institute for Public Health and the Environment, Centre for Infectious Diseases Control, Bilthoven, the Netherlands., Rodrigues AP; Epidemiology Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal., Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain., Mlinarić I; Croatian Institute of Public Health, Zagreb, Croatia., Latorre-Margalef N; Public Health Agency of Sweden, Stockholm, Sweden., Túri G; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Lazăr M; Cantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania., Mazagatos C; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Echeverria A; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain., Abela S; Infectious Disease Prevention and Control Unit (IDCU), Health Promotion and Disease Prevention, Msida, Malta., Bourgeois M; Department of Infectious Diseases, CHU UCL Namur (site Godinne), Université catholique de Louvain, Yvoir, Belgium., Machado A; Epidemiology Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal., Dürrwald R; National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany., Petrović G; Croatian Institute of Public Health, Zagreb, Croatia., Oroszi B; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Jancoriene L; Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania., Marin A; Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania., Husa P; University Hospital Brno and Masaryk University, Brno, Czechia., Duffy R; HSE Health Protection Surveillance Centre, Dublin, Ireland., Dijkstra F; National Institute for Public Health and the Environment, Centre for Infectious Diseases Control, Bilthoven, the Netherlands., Gallardo García V; Servicio de Vigilancia y Salud Laboral, Dirección General de Salud Pública y Ordenación Farmacéutica, Consejería de Salud y Consumo, Andalucía, Spain., Goerlitz L; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany., Enouf V; Centre National de Référence Virus des Infections Respiratoire (CNR VIR), Institut Pasteur Université Paris Cité, Paris, France., Bennett C; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland., Hooiveld M; Nivel, Utrecht, the Netherlands., Guiomar R; Laboratório Nacional Referência Gripe e outros Vírus Respiratórios, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal., Trobajo-Sanmartín C; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain., Višekruna Vučina V; Croatian Institute of Public Health, Zagreb, Croatia., Samuelsson Hagey T; Public Health Agency of Sweden, Stockholm, Sweden., Lameiras Azevedo AS; Servicio de vigilancia y control epidemiológico, Subdirección general de Epidemiología y Vigilancia de la Salud, Dirección General de Salud pública, Valencia, Spain., Castilla J; Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain., Xuereb G; Department of Child and Adolescent Health, Mater Dei Hospital, Msida, Malta.; Infectious Disease Prevention and Control Unit (IDCU), Health Promotion and Disease Prevention, Msida, Malta., Delaere B; Department of Infectious Diseases, CHU UCL Namur (site Godinne), Université catholique de Louvain, Yvoir, Belgium., Gómez V; Epidemiology Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal., Tolksdorf K; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany., Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden., Nicolay N; European Centre for Disease Prevention and Control, Stockholm, Sweden., Kaczmarek M; European Centre for Disease Prevention and Control, Stockholm, Sweden., Rose AM; Epiconcept, Paris, France.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Feb; Vol. 29 (8).